Cover Image

Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]

Cristina Montrasio,1 Stefania Cheli,1 Emilio Clementi2,3 1Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy; 2Clinical Pharmacology Unit, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università degli Stu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Montrasio C (Author), Cheli S (Author), Clementi E (Author)
Format:	Book
Published:	Dove Medical Press, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]
by: López López-Cepero M, et al.
Published: (2023)

Response to "DPYD genotyping panels: Impact of population diversity"
by: Andrea Gaedigk, et al.
Published: (2024)

DPYD genotyping panels: Impact of population diversity
by: Guilherme Suarez‐Kurtz
Published: (2024)

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
by: Georgia Ragia, et al.
Published: (2023)

A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping
by: Jean De Dieu Ndayishimiye, et al.
Published: (2024)

Reply to "A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping"
by: Nihal El Rouby, et al.
Published: (2024)

“Dynamic Monitoring of Hypothyroidism During Pregnancy” article [Response to Letter]
by: Abadi KK
Published: (2023)

DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
by: Angela Wu, et al.
Published: (2023)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
by: Evou KE, et al.
Published: (2021)

Response to “Considering the Potential Benefits of Over-the-Counter Naloxone” by Evoy et al [Letter]
by: Fuehrlein B
Published: (2021)

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
by: Montrasio C, et al.
Published: (2023)

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature
by: White C, et al.
Published: (2021)

Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing
by: Amy J. Turner, et al.
Published: (2024)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
by: Ursina B. M. Begré, et al.
Published: (2022)

“Brain drain” and “brain waste”: experiences of international medical graduates in Ontario
by: Lofters A, et al.
Published: (2014)

Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population
by: Eiji Hishinuma, et al.
Published: (2022)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
by: Anthi Maslarinou, et al.
Published: (2023)

<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
by: Theodore J. Wigle, et al.
Published: (2019)

Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center
by: Megan Muldoon, et al.
Published: (2024)

Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
by: A. Bignucolo, et al.
Published: (2023)

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of <i>DPYD</i> Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study
by: Xando Díaz-Villamarín, et al.
Published: (2024)

Response to “Sexual Harassment Among Chinese Psychiatrists and Its Impact on Quality of Life: A Cross-Sectional Survey” [Letter]
by: Yao L, et al.
Published: (2024)

Response to Article “Evaluation of the Anti-Malarial Activity of the Crude Root Extract and Solvent Fraction of Sesamum indicum (Fabaceae)” [Letter]
by: Intan PR, et al.
Published: (2023)

Critical Response to Article “Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis” [Letter]
by: Rinendyaputri R, et al.
Published: (2023)

A Response to “Healthcare Workers’ Emotions, Stressor Experiences and Coping Strategies During the COVID-19 Pandemic in Vietnam” [Letter]
by: Gupta A, et al.
Published: (2021)

Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Response to Letter]
by: Zhou L, et al.
Published: (2023)

Response to “Rampart of Health-Specific Leadership and Social Support of Colleagues to Overcome Burnout in an Emotionally Demanding Situations: The Mediating Role of Stress” [Letter]
by: Prayitno H, et al.
Published: (2023)

A Response to “Predictors of Intention to Get a COVID-19 Vaccine of Health Science Students: A Cross-Sectional Study.” [Letter]
by: Gupta A, et al.
Published: (2021)

A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
by: Panjaitan NSD, et al.
Published: (2022)

Thoughts on “Prevalence of Risk Factors for Hypertension Among Faculty at an Urban University in Uganda” [Letter]
by: Sadeghi M, et al.
Published: (2024)

Measurement Equivalence of “Touch-Screen” versus “Paper-Based” Assessments of OHRQoL: A Randomized Crossover Trial
by: Anowar M, et al.
Published: (2020)

Be wary of “natural” therapy in gynecological surgery
by: Erian M, et al.
Published: (2013)

Self-management: keeping it simple with “Flo”
by: Cund A, et al.
Published: (2015)

A novel large intragenic DPYD deletion causing dihydropyrimidine dehydrogenase deficiency: a case report
by: Anna Malekkou, et al.
Published: (2024)

Response to Article “Antipyretic Potential of 80% Methanol Extract and Solvent Fractions of Bersama abyssinica Fresen. (Melianthaceae) Leaves Against Yeast-Induced Pyrexia in Mice” [Response to Letter]
by: Tegegne BA, et al.
Published: (2023)

Response to Article “Evaluation of the Antioxidant and Wound Healing Properties of 80% Methanol Extract and Solvent Fractions of the Leaves of Vernonia auriculifera Hiern. (Asteraceae)” [Letter]
by: Intan PR, et al.
Published: (2023)

Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Letter]
by: Maha MS, et al.
Published: (2023)

Critical Response to Article “Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer” [Letter]
by: Dany F, et al.
Published: (2023)

Response to “Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5 + Dermatomyositis: A Retrospective Study in China” [Letter]
by: Prisusanti RD, et al.
Published: (2024)